-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
-
Summary
-
Arbutus Biopharma Corp quarterly Assets history and growth rate from Q4 2010 to Q4 2013.
- Arbutus Biopharma Corp Assets for the quarter ending December 31, 2013 was CA$71.7M, a 36.4% increase year-over-year.
Assets, Quarterly (CAD)
Assets, YoY Quarterly Growth (%)